Johnson & Johnson to Participate in Citi's Global Healthcare Conference
More News related to JNJ
- Omrix Biopharmaceuticals (OMRI) Enrolls First Patient in Phase II Trials for its Fibrin Pad
- ETHICON Receives Offer from One Equity Partners to Purchase Professional Wound Care Business
- Janssen Announces Launch of Authorized Generic for RISPERDAL(R) Through Patriot Pharma (JNJ)
- Janssen Announces Launch of Authorized Generic for RISPERDAL(R)
- American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses
More News related to Press Releases
- NASCAR(R) Driver Kyle Petty Comes Through for Fans Around the Country with Offer of Free Coke Zero
- Lottery's Millionaire Raffle Drawing Creates Four New Millionaires
- Big Spin(R) Contestant Plans Shoe Shopping Spree
- Press Gaggle by Dana Perino, Dan Price, Assistant to the President for International Economic Affairs, and Dennis Wilder, NSC Senior Director for Asian Affairs
- Farmers Insurance Claims Teams Helping Customers in or Near the Goleta, California Wildfires
NEW BRUNSWICK, N.J., May 15 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in Citi's Global Healthcare Conference on Thursday, May 22nd, at the Hilton New York in New York City. Sheri McCoy, Worldwide Chairman, Surgical Care, will represent the Company in a session scheduled at 10:30 a.m. (Eastern Time).
The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately two hours after the live webcast.
SOURCE Johnson & Johnson
Related Categories
Press ReleasesStocks Mentioned
+0.48Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
